Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Müller

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Electrophoresis|December 1, 1993
Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresisT Blunk, D F Hochstrasser, J C Sanchez, et al.
International Journal of Pharmaceutics|March 18, 2018
Liposomes, lipid nanocapsules and smartCrystals®: A comparative study for an effective quercetin delivery to the skinT Hatahet, M Morille, A Hommoss, et al.
Journal of Drug Targeting|January 1, 1997
The influence of the sample preparation on plasma protein adsorption patterns on polysaccharide-stabilized iron oxide particles and N-terminal microsequencing of unknown proteinsK Thode, M Lück, W Schröder, et al.
International Journal of Pharmaceutics|December 3, 2014
Novel oral phosphate binder with nanocrystalline maghemite-phosphate binding capacity and pH effectT M-H Nguyen, R H Müller, M Taupitz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 31, 1998
Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer compositionM Lück, K F Pistel, Y X Li, et al.
International Journal of Pharmaceutics|April 4, 2006
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystalsR H Müller, S Runge, V Ravelli, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosisN Schöler, K Krause, O Kayser, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 7, 2007
Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporationR H Müller, S A Runge, V Ravelli, et al.
Advanced Drug Delivery Reviews|August 30, 2014
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheresR Gref, A Domb, P Quellec, et al.
Die Pharmazie|March 1, 2013
Influence of particle shape on plasma protein adsorption and macrophage uptakeM Jansch, A B Jindal, B Majee Sharmila, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Electrophoresis|December 1, 1993
Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresisT Blunk, D F Hochstrasser, J C Sanchez, et al.
International Journal of Pharmaceutics|March 18, 2018
Liposomes, lipid nanocapsules and smartCrystals®: A comparative study for an effective quercetin delivery to the skinT Hatahet, M Morille, A Hommoss, et al.
Journal of Drug Targeting|January 1, 1997
The influence of the sample preparation on plasma protein adsorption patterns on polysaccharide-stabilized iron oxide particles and N-terminal microsequencing of unknown proteinsK Thode, M Lück, W Schröder, et al.
International Journal of Pharmaceutics|December 3, 2014
Novel oral phosphate binder with nanocrystalline maghemite-phosphate binding capacity and pH effectT M-H Nguyen, R H Müller, M Taupitz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 31, 1998
Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer compositionM Lück, K F Pistel, Y X Li, et al.
International Journal of Pharmaceutics|April 4, 2006
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystalsR H Müller, S Runge, V Ravelli, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosisN Schöler, K Krause, O Kayser, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 7, 2007
Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporationR H Müller, S A Runge, V Ravelli, et al.
Advanced Drug Delivery Reviews|August 30, 2014
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheresR Gref, A Domb, P Quellec, et al.
Die Pharmazie|March 1, 2013
Influence of particle shape on plasma protein adsorption and macrophage uptakeM Jansch, A B Jindal, B Majee Sharmila, et al.
Pageof 14